BOCA RATON, FL, Aug. 14 /PRNewswire-FirstCall/ -- Stem Cell Assurance announced today that in line with the positive corporate changes, and agreed capital investment, will now be conducting all it's business as Stem Cell Assurance, Inc. with its new ticker symbol being SCLZ. These developments facilitate the company's expansion into multiple centers, beauty and healthcare ranges and alliances as announced in its business plan. Detailed information will be issued to the shareholders by the Company on all of these matters. "The timing was right to re-align our corporate presence to coincide with recent developments" said Gloria McConnell, President. "The success the company has made with its capital investment program has created new centers, joint ventures, professional alliances and an ever growing patient base demanded a change to our new identity." About Stem Cell Assurance Stem Cell Assurance is one of the nation's first companies to provide adult stem cell collection and banking services to the general adult population. The collection process that Stem Cell Assurance provides has been medically proven to be the least invasive, painless and the safest form of adult stem cell collection. We are a company of doctors and scientists that specialize in the collection, processing, and long term storage of your own adult stem cells for your own therapeutic use in the future, if the need arises. See http://www.stemcellassurance.com/ for more information. Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements. DATASOURCE: Stem Cell Assurance Inc. CONTACT: Investor Relations Contact: George Dubec, Stem Cell Assurance, (561) 362-4142, , http://www.stemcellassurance.com/

Copyright